General Description
Demecarium Bromide is a long-acting anticholinesterase agent of the quaternary ammonium carbamate class, primarily developed for ophthalmic use. Its bis-quaternary structure consists of two physostigmine-like carbamate units linked by a decamethylene chain, which confers prolonged cholinesterase inhibitory activity.
Mechanism of Action
Demecarium Bromide irreversibly inhibits acetylcholinesterase and pseudocholinesterase by carbamylating the active site serine residue, preventing hydrolysis of acetylcholine at cholinergic synapses. This prolonged enzyme inhibition results in sustained accumulation of acetylcholine at neuromuscular junctions and parasympathetic nerve endings.
Application
Used in ophthalmology for the treatment of accommodative esotropia and certain types of glaucoma. Demecarium Bromide is a long-acting cholinesterase inhibitor that produces sustained miosis and contraction of the ciliary muscle, particularly useful in the management of accommodative strabismus and angle-closure glaucoma adjunctive therapy.